Idea - FICS

Patient compliance

Team and Contact Details

Student Name School Degree Year Email
Dr. Muhammad ZamanPHARMACYMS/M.PhilSecond[email protected]
Muhammad Sajid NawazPHARMACYMS/M.PhilSecond[email protected]

Inter School Idea ? Yes
Do you need expertises from another area: No
If Yes please provide details of expertises you need:

Idea Details

Idea Name: Patient compliance
Slogan: Enabling Healthy Happy Lives
Supervisor Name: Dr. Muhammad Zaman
Supervisor Designation: Associate Professor, Faculty of Pharmacy, University of Central Punjab
Supervisor School: Other
Supervisor Department: PHARMACY
Contact number: +92 300 6095928
Email ID: [email protected]
Abstract:
    The goal of the research was to prepare a single dosage unit for the cure of Allergic Rhinitis, to enhance the patient compliance and to reduce the frequency of dosing. This combination was concluded to be safe and effective as per previous researches.
What is the unmet need in society that your idea will fulfill ?
    Due to socio-economical conditions of Pakistan & Pharmaceutical industries, there is need of combination of Drugs in one unit. Impact of this Formulation in terms of cost effectiveness will be bigger.
Who needs it ? How many would benefit ?
   Now a days, there are millions of people that are suffering from allergic rhinitis and common cold. The most recommended drug combination is antihistamine and non-steroidal anti-inflammatory drugs which is not available in a single dosage unit so successfully developed in a single dosage unit
How will the solution works
    The most simple and effective method of treatment is still oral solid dosage forms. It is the suitable route because of benefits such as non-invasiveness, patients conformance, and ease of drug administration. In this study pellets of Fexofenadine IR and Paracetamol SR has been successfully developed and encapsuled in a single dosage unit in a hard gelatin capsule. This is developed by extrusion spehronization technique
Who are your competitors ? How is your solution different
    No competitor with this combination.
Status: new
Entry Date & Time: 2022-12-30 (0657)